GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Quest Diagnostics Inc (MEX:DGX) » Definitions » Research & Development

Quest Diagnostics (MEX:DGX) Research & Development : MXN0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Quest Diagnostics Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Quest Diagnostics's Research & Development for the three months ended in Sep. 2024 was MXN0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was MXN0 Mil.

Quest Diagnostics Research & Development Historical Data

The historical data trend for Quest Diagnostics's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quest Diagnostics Research & Development Chart

Quest Diagnostics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Quest Diagnostics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Quest Diagnostics Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quest Diagnostics  (MEX:DGX) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Quest Diagnostics Research & Development Related Terms

Thank you for viewing the detailed overview of Quest Diagnostics's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Quest Diagnostics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Quest Diagnostics Inc (MEX:DGX) » Definitions » Research & Development
Comparable Companies
ICLR LH NTRA WAT ILMN RVTY MTD MEDP CRL EXAS TMO DHR XSWX:LONN A IQV IDXX SHSE:603259 XPAR:BIM QGEN XPAR:ERF
Traded in Other Exchanges
DGX:USA 0KSX:UK QDI:Germany QDI:Germany Q1UE34:Brazil
Address
500 Plaza Drive, Secaucus, NJ, USA, 07094
Website
https://www.questdiagnostics.com
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the us. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.